Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,556 | 55 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $263.86 | 8 | $0 (2024) |
| Clovis Oncology, Inc. | $263.62 | 18 | $0 (2019) |
| TESARO, Inc. | $222.72 | 4 | $0 (2019) |
| Eisai Inc. | $217.81 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $202.47 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $150.53 | 3 | $0 (2022) |
| Intuitive Surgical, Inc. | $81.67 | 1 | $0 (2017) |
| Helsinn Therapeutics (U.S.), Inc. | $50.03 | 3 | $0 (2019) |
| Kyowa Kirin, Inc. | $44.31 | 3 | $0 (2018) |
| ABBVIE INC. | $25.78 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.30 | 7 | Eisai Inc. ($100.61) |
| 2023 | $92.12 | 4 | GlaxoSmithKline, LLC. ($51.32) |
| 2022 | $260.57 | 7 | GlaxoSmithKline, LLC. ($98.63) |
| 2021 | $135.63 | 3 | AstraZeneca Pharmaceuticals LP ($102.60) |
| 2020 | $46.27 | 2 | AstraZeneca Pharmaceuticals LP ($24.93) |
| 2019 | $316.15 | 10 | TESARO, Inc. ($211.26) |
| 2018 | $201.68 | 18 | Clovis Oncology, Inc. ($149.93) |
| 2017 | $283.72 | 4 | Merck Sharp & Dohme Corporation ($105.56) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: ONCOLOGY | ||||||
| 05/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $77.94 | General |
| Category: Oncology | ||||||
| 03/05/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Oncology | ||||||
| 02/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: ONCOLOGY | ||||||
| 02/15/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: ONCOLOGY | ||||||
| 01/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: ONCOLOGY | ||||||
| 07/06/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2023 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.53 | General |
| Category: Oncology | ||||||
| 04/04/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: ONCOLOGY | ||||||
| 03/30/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ONCOLOGY | ||||||
| 07/28/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ONCOLOGY | ||||||
| 05/11/2022 | AstraZeneca Pharmaceuticals LP | FASLODEX (Drug) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Oncology | ||||||
| 04/21/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $63.51 | General |
| Category: Oncology | ||||||
| 04/21/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $13.66 | General |
| Category: Oncology | ||||||
| 03/31/2022 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $98.63 | General |
| Category: ONCOLOGY | ||||||
| 03/31/2022 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Oncology | ||||||
| 01/13/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ONCOLOGY | ||||||
| 08/05/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $102.60 | General |
| Category: Oncology | ||||||
| 08/19/2020 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: Oncology | ||||||
| 07/21/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2019 | Tactile Systems Technology Inc | FLEXITOUCH (Device), ACTITOUCH, ENTRE | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 11/20/2019 | Becton, Dickinson and Company | PROGEL (Device) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: INTERVENTIONAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 58 | 204 | $98,220 | $35,697 |
| 2022 | 3 | 97 | 305 | $111,440 | $52,802 |
| 2021 | 4 | 99 | 250 | $99,496 | $43,207 |
| 2020 | 4 | 109 | 250 | $184,420 | $34,578 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 187 | $91,480 | $33,498 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 17 | $6,740 | $2,199 | 32.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 216 | $92,880 | $40,918 | 44.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 24 | 62 | $11,000 | $8,355 | 76.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 27 | $7,560 | $3,530 | 46.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 188 | $80,840 | $35,400 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 28 | $7,840 | $3,838 | 49.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 18 | $3,360 | $2,181 | 64.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 11 | 16 | $7,456 | $1,788 | 24.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 56 | 168 | $72,240 | $25,013 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 41 | $11,480 | $4,406 | 38.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 29 | $5,500 | $3,293 | 59.9% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 12 | 12 | $95,200 | $1,865 | 2.0% |
About Dr. Linda Smith, MD
Dr. Linda Smith, MD is a Emergency Medicine healthcare provider based in Anchorage, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2007. The National Provider Identifier (NPI) number assigned to this provider is 1497888267.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Linda Smith, MD has received a total of $1,556 in payments from pharmaceutical and medical device companies, with $220.30 received in 2024. These payments were reported across 55 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,556).
As a Medicare-enrolled provider, Smith has provided services to 363 Medicare beneficiaries, totaling 1,009 services with total Medicare billing of $166,283. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Anchorage, AK
- Active Since 03/13/2007
- Last Updated 10/24/2008
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1497888267
Products in Payments
- ZEJULA (Drug) $412.46
- Rubraca (Drug) $240.72
- Lenvima (Drug) $217.81
- KEYTRUDA (Biological) $202.47
- LYNPARZA (Drug) $127.53
- Da Vinci Surgical System (Device) $81.67
- JEMPERLI (Biological) $74.12
- AKYNZEO (Drug) $50.03
- SANCUSO (Drug) $44.31
- ELAHERE (Drug) $25.78
- FASLODEX (Drug) $23.00
- PROGEL (Device) $17.76
- FLEXITOUCH (Device) $15.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Anchorage
Michael Levy, M.d, M.D
Emergency Medicine — Payments: $185,300
John Schwab, Md, MD
Emergency Medicine — Payments: $450.34
Jennifer Dow, M.d, M.D
Emergency Medicine — Payments: $241.43
Jane Heisel, Md, MD
Emergency Medicine — Payments: $181.25
Anson Cheng, Md, MD
Emergency Medicine — Payments: $137.26
Dr. Blaine Norton, M.d, M.D
Emergency Medicine — Payments: $121.87